Stockreport

Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TE...

Inventiva S.A. - American Depository Shares  (IVA) 
PDF This report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Non-Alcoholic Steatohepatitis (NASH) pipeline landscape. It covers the pipel [Read more]